Home Physical Sciences Crystal structure of (E)-(4-imidazol-1-yl-phenyl)-(2-methoxy-benzylidene)-amine monohydrate, C17H17N3O2
Article Open Access

Crystal structure of (E)-(4-imidazol-1-yl-phenyl)-(2-methoxy-benzylidene)-amine monohydrate, C17H17N3O2

  • Lufei Xiao ORCID logo , Jie Li , Qirui Liang and Jie Liu ORCID logo EMAIL logo
Published/Copyright: March 10, 2022
Download Article (PDF)
Become an author with De Gruyter Brill
Submit Manuscript Author Information
Zeitschrift für Kristallographie - New Crystal Structures
From the journal Zeitschrift für Kristallographie - New Crystal Structures Volume 237 Issue 3

Abstract

C17H17N3O2, monoclinic, P21/c (no. 14), a = 10.655(5) Å, b = 5.056(5) Å, c = 28.712 Å, β = 99.034(1)°, V = 1527.6(17) Å3, Z = 4, R gt (F) = 0.0520, wR ref(F 2) = 0.1611, T = 298(2) K.

CCDC no.: 1851609

The molecular structure is shown in the figure. Table 1 contains crystallographic data and Table 2 contains the list of the atoms including atomic coordinates and displacement parameters.

Table 1:

Data collection and handling.

Crystal: Colorless block
Size: 0.30 × 0.20 × 0.20 mm
Wavelength: Mo Kα radiation (0.71073 Å)
μ: 0.09 mm−1
Diffractometer, scan mode: Bruker Smart Apex, ω
θ max, completeness: 25.0°, >99%
N(hkl)measured, N(hkl)unique, R int: 10,113, 2663, 0.033
Criterion for I obs, N(hkl)gt: I obs > 2 σ(I obs), 1943
N(param)refined: 227
Programs: Bruker [1], Olex2 [2], SHELX [3]
Table 2:

Fractional atomic coordinates and isotropic or equivalent isotropic displacement parameters (Å2).

Atom x y z U iso*/U eq
C1Aa 0.0757 (5) 0.0162 (7) −0.05858 (12) 0.0932 (12)
H1Aa 0.081909 −0.074216 −0.030103 0.112*
C1Bb −0.0008 (8) 0.130 (2) −0.0625 (3) 0.063 (2)
H1Bb −0.044410 0.136482 −0.036883 0.075*
C2Aa 0.0112 (5) −0.0629 (10) −0.10036 (19) 0.0782 (13)
H2Aa −0.042280 −0.209061 −0.104756 0.094*
C2Bb −0.0379 (13) 0.020 (3) −0.1031 (6) 0.075 (4)
H2Bb −0.106062 −0.096709 −0.109572 0.090*
C3 0.1129 (3) 0.2678 (7) −0.11160 (8) 0.1042 (10)
H3 0.154129 0.394777 −0.127132 0.125*
C4 0.2051 (2) 0.4062 (4) −0.03099 (7) 0.0722 (6)
C5 0.1788 (3) 0.4169 (5) 0.01415 (7) 0.0974 (9)
H5 0.111548 0.318975 0.022229 0.117*
C6 0.2511 (3) 0.5714 (5) 0.04774 (8) 0.1027 (10)
H6 0.232183 0.576394 0.078266 0.123*
C7 0.3503 (3) 0.7171 (5) 0.03669 (9) 0.0877 (8)
C8 0.3760 (3) 0.7033 (8) −0.00882 (11) 0.1262 (13)
H8 0.443450 0.800059 −0.017069 0.151*
C9 0.3036 (3) 0.5488 (7) −0.04228 (10) 0.1161 (12)
H9 0.322503 0.542272 −0.072799 0.139*
C10 0.3899 (2) 0.9940 (5) 0.10190 (8) 0.0783 (7)
H10 0.302850 0.992150 0.102344 0.094*
C11 0.4732 (2) 1.1430 (4) 0.13828 (7) 0.0740 (7)
C12 0.6036 (3) 1.1094 (6) 0.14438 (9) 0.0933 (8)
H12 0.638103 0.989457 0.125324 0.112*
C13 0.6842 (3) 1.2497 (6) 0.17814 (9) 0.0940 (8)
H13 0.771565 1.223038 0.181844 0.113*
C14 0.6342 (3) 1.4269 (5) 0.20585 (8) 0.0896 (8)
H14 0.688017 1.524333 0.228102 0.107*
C15 0.5047 (3) 1.4634 (5) 0.20128 (7) 0.0821 (7)
H15 0.471542 1.584219 0.220550 0.099*
C16 0.4233 (2) 1.3198 (4) 0.16785 (7) 0.0718 (6)
C17 0.2357 (3) 1.5125 (6) 0.19105 (9) 0.1009 (9)
H17A 0.260398 1.459579 0.223290 0.151*
H17B 0.144949 1.501676 0.182859 0.151*
H17C 0.262619 1.691276 0.187145 0.151*
N1 0.12871 (18) 0.2476 (4) −0.06562 (6) 0.0704 (5)
N2 0.0348 (2) 0.0954 (5) −0.13374 (7) 0.0881 (7)
N3 0.4337 (2) 0.8684 (5) 0.07002 (8) 0.0993 (8)
O1 0.29396 (17) 1.3413 (4) 0.16099 (5) 0.0878 (6)
O3 0.0365 (2) 0.9465 (4) 0.23458 (7) 0.0980 (7)
H3A 0.006 (3) 0.944 (8) 0.2040 (14) 0.145 (13)*
H3B 0.008 (4) 1.121 (9) 0.2434 (14) 0.156 (14)*

  1. aOccupancy: 0.75, bOccupancy: 0.25.

Source of material

All chemicals were purchased from commercial sources and used as received without further purification. The 4-imidazol-1-yl-phenylamine (2.45 mmol, 0.39 g) and 2-methoxy-benzaldehyde (6.98 mmol, 0.95 g) were dissolved in EtOH (25 mL). The mixture was refluxed for 8 h, and then the precipitate was collected by filtration and washed with EtOH. The product was recrystallized from a mixture of ethyl acetate and cyclohexane to afford colorless crystals. Yield: 0.51 g (75.5%). m.p.: 84.1–85.5 °C. 1 H NMR (CDCl3, 400 MHz, ppm): δ 8.95 (s, 1H), 8.15 (dd, J = 7.76 Hz, 1.80 Hz, 1H), 7.89 (s, 1H), 7.48 (td, J = 7.88 Hz, 1.76 Hz, 1H), 7.41 (dt, J = 8.76 Hz, 2.68 Hz, 2H), 7.34–7.30 (m, 3H), 7.23–7.15 (m, 2H), 7.08–7.05 (m, 1H), 3.92 (s, 3H).

Experimental details

All H-atoms bonded to C-atoms were placed geometrically and refined using a riding model with common isotropic displacement factors U iso(H) = 1.2 or 1.5 U eq (parent C-atom).

Comment

The imidazole ring is broadly present in many natural products from a diversity of sources and is a key structural motif of essential biomolecules such as nucleic acids, purine, histamine, and histidine [4]. Imidazole-containing compounds feature relevant biological activities and show a lot of therapeutic activities [4], [5], [6]. Furthermore, due to their photophysical and chemical properties as well as their good thermal stability, the imidazole derivatives are functional materials [7], [8], [9]. The title compound was synthesized by the aldehyde-amine condensation reaction to give the Schiff base, which has wide research in biology and chemistry [10, 11].

The title molecule exhibits an E configuration. The bond length of C10=N3 is 1.262 Å. The diheral angle of the two aromatic rings is 50.71°. The angle of C11–C10=N3 and C7–N3=C10 are 121.54° and 119.69°, respectively. The bond length of C10–C11 is 1.468 Å, shorter than normal C–C single bonds (1.54 Å). The geometric parameters are similar to those seen in the structures of related compounds [12, 13].

Corresponding author: Jie Liu, School of Chemistry and Material Engineering, Fuyang Normal University, Fuyang, Anhui 236041, China, E-mail:

Funding source: Anhui Provincial Department of Education

Award Identifier / Grant number: KJ2017ZD49

Award Identifier / Grant number: KJ2018A0842

Award Identifier / Grant number: KJ2019A0545

Funding source: National and Anhui College Student Innovation and Entrepreneurship Program

Award Identifier / Grant number: 202110371010

Award Identifier / Grant number: S202010371057

Funding source: The Ministry of Education Industry-University Cooperation Collaborative Education Project

Award Identifier / Grant number: 202101052045

Funding source: School Level Online and Offline Mixed First-class Courses of Organic Chemistry Experiment

Award Identifier / Grant number: 2020HEYL02

  1. Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.

  2. Research funding: This work was supported by the foundation programs as follows: Natural Science Research Program under Anhui Provincial Department of Education (KJ2017ZD49, KJ2018A0842, KJ2019A0545); National and Anhui College Student Innovation and Entrepreneurship Program (202110371010, S202010371057); The Ministry of Education Industry-University Cooperation Collaborative Education Project (202101052045); School Level Online and Offline Mixed First-class Courses of Organic Chemistry Experiment (2020HEYL02).

  3. Conflict of interest statement: The authors declare no conflicts of interest regarding this article.

References

1. Bruker. SMART, SAINT and SADABS; Bruker AXS Inc.: Madison, WI, USA, 2009.Search in Google Scholar

2. Dolomanov, O. V., Bourhis, L. J., Gildea, R. J., Howard, J. A. K., Puschmann, H. OLEX2: a complete structure solution, refinement and analysis program. J. Appl. Crystallogr. 2009, 42, 339–341; https://doi.org/10.1107/s0021889808042726.Search in Google Scholar

3. Sheldrick, G. M. Crystal structure refinement with SHELXL. Acta Crystallogr. 2015, C71, 3–8; https://doi.org/10.1107/s2053229614024218.Search in Google Scholar

4. Medeiros, A. R., Ferreira, L. L. G., Souza, M. L. D., Junior, C. D. O. R., Espinoza-Chavez, R. M., Dias, L. C., Andricopulo, A. D. Chemoinformatics studies on a series of imidazoles as cruzain inhibitors. Biomolecules 2021, 11, 579–597; https://doi.org/10.3390/biom11040579.Search in Google Scholar

5. Zhang, L., Peng, X. M., Damu, G. L., Geng, R. X., Zhou, C. H. Comprehensive review in current developments of imidazole-based medicinal chemistry. Med. Res. Rev. 2014, 34, 340–437; https://doi.org/10.1002/med.21290.Search in Google Scholar

6. Siwach, A., Verma, P. K. Synthesis and therapeutic potential of imidazole containing compounds. BMC Chem. 2021, 12, 12; https://doi.org/10.1186/s13065-020-00730-1.Search in Google Scholar

7. Ye, S. F., Zhuang, S. Q., Pan, B., Guo, R. D., Wang, L. Imidazole derivatives for efficient organic light emitting diodes. J. Inf. Disp. 2020, 21, 173–196; https://doi.org/10.1080/15980316.2020.1802357.Search in Google Scholar

8. Lei, Z. W., Jin, X., Li, J. M., Liu, Y., Jiao, S. H., Cao, R. G. Tuning electrochemical transformation process of zeolitic imidazolate framework for efficient water oxidation activity. J. Energy Chem. 2022, 65, 505–513; https://doi.org/10.1016/j.jechem.2021.06.019.Search in Google Scholar

9. Ali, A. M., Liu, X. F., Li, Y., Ren, J. J., Qiu, J. R. Nonlinear-optical response in zeolitic imidazolate framework glass. Inorg. Chem. 2020, 59, 8380–8386; https://doi.org/10.1021/acs.inorgchem.0c00806.Search in Google Scholar

10. Tang, Q., Hu, J., Ding, Y. J., Zhang, Y. F., Li, H. F., Xu, M., Yang, X. C., Liang, L. L., Li, W. G. Syntheses structures and antimicrobial properties of complexes based on 2-hydroxybenzaldehyde-4-aminoantipyrine Schiff base. J. Coord. Chem. 2021, 74, 4–6; https://doi.org/10.1080/00958972.2021.1875449.Search in Google Scholar

11. Zhang, J., Xu, L. L., Wong, W. Y. Energy materials based on metal Schiff base complexes. Coord. Chem. Rev. 2018, 355, 180–198; https://doi.org/10.1016/j.ccr.2017.08.007.Search in Google Scholar

12. Ceyhan, G., Köse, M., Tümer, M., Demirtaş, İ. Anticancer, photoluminescence and electrochemical properties of structurally characterized two imine derivatives. Spectrochim. Acta, Part A 2015, 149, 731–743; https://doi.org/10.1016/j.saa.2015.05.021.Search in Google Scholar

13. Ojala, W. H., Arola, T. M., Herrera, N., Balidemaj, B., Ojala, C. R. Isomeric Schiff bases related by dual imino-group reversals. Acta Crystallogr. 2007, 63, o207–o211; https://doi.org/10.1107/s0108270107006233.Search in Google Scholar
Received: 2022-01-15
Accepted: 2022-02-07
Published Online: 2022-03-10
Published in Print: 2022-06-27

© 2022 Lufei Xiao et al., published by De Gruyter, Berlin/Boston

This work is licensed under the Creative Commons Attribution 4.0 International License.

Articles in the same Issue

  1. Frontmatter
  2. New Crystal Structures
  3. Crystal structure of (E)-(4-imidazol-1-yl-phenyl)-(2-methoxy-benzylidene)-amine monohydrate, C17H17N3O2
  4. Crystal structure of 6-methyl-3-(pyrrolidine-1-carbonyl)-2H-chromen-2-one, C15H15N1O3
  5. Crystal structure of 4-methyl-4-nitropentanoic acid, C6H11NO4
  6. The crystal structure of (E)-3-(furan-2-yl)acrylonitrile, C7H5NO
  7. Crystal structure of 3-(difluoromethyl)-1-methyl-N-(4,11,11-trimethyl-1,2,3,4-tetrahydro-1,4-methanoacridin-9-yl)-1H-pyrazole-4-carboxamide monohydrate, C23H26F2N4O3
  8. Crystal structure of 2-(4-bromobenzyloxy)-6-chloropyridine, C12H9BrClNO
  9. Crystal structure of N-(4-bromo-2,6-dichloro-phenyl)pyrazin-2-amine, C10H6BrCl2N3
  10. Crystal structure of (E)-1-(2–nitrophenyl)-3-phenylprop-2-en-1-one, C15H11NO3
  11. The crystal structure of (E)-3-chloro-2-(2-(4-fluorobenzylidene)hydrazinyl)pyridine, C12H9ClFN3
  12. Crystal structure of (E)-amino(2-(thiazol-2-ylmethylene)hydrazineyl)methaniminium nitrate, C10H16N12O6S2
  13. Crystal structure of 9-methoxy-2,3,4,4a,5,6-hexahydro-1H-pyrido [1′,2′:1,6]pyrazino[2,3-b]quinoxaline, C15H18N4O
  14. The crystal structure bis(dimethylsulfoxide-κ1O)-dipyridine-κ1 N-bis(m2-(Z)-3-methyl-2-oxido-N-((Z)-oxido(phenyl)methylene)benzohydrazonato-κ5)trinickel(II) - dimethylsulfoxide (1/2), C48H56N6Ni3O10S4
  15. Crystal structure of bis(bis(triphenylphosphine)iminium) tetradecacarbonyltetratelluridopentaferrate(2-), (PPN)2[Fe5Te4(CO)14]
  16. Crystal structure of 4-Hydroxy-3-(naphthalen-2-ylthio)pent-3-en-2-one, C15H14O2S
  17. The crystal structure of [(1,10-phenanthroline-κ2 N,N)-bis(6-phenylpyridine-2-carboxylate-κ2 N,O)nickel(II)] monohydrate, C36H26N4O5Ni
  18. Crystal structure of 3,3′-(pyridine-2,6-diylbis(methylene))bis(1-propyl-1H-imidazol-3-ium) ditetrafluoroborate, C19H27B2F8N5
  19. The crystal structure of (E)-1-(4-aminophenyl)-3-(p-tolyl)prop-2-en-1-one, C16H15NO
  20. The crystal structure of poly[(μ2-terephthalato-κ4O,O′: O″,O‴)-(μ4-terephthalato-κ4O:O′:O″:O‴)-{μ4-(1,2,4,5-tetrakis(1,2,4-triazol-1-ylmethyl)-benzene-κ4O:O′:O″,O‴)}dicadmium(II)] – water – acetronitrile (1/2/2), C38H36N14O10Cd2
  21. The crystal structure of diaqua-bis(6-phenylpyridine-2-carboxylato-κ2 N,O)cobalt(II)–water–N,N-dimethylformamide(1/2/1), C27H31N3O9Co
  22. The co-crystal structure of 4-hydroxy-3-methoxybenzoic acid – 4,4′-bipyridine, C8H8O4·C10H8N2
  23. Crystal structure of catena-poly[(μ2-1,1′-(biphenyl-4,4′-diyl)bis(1H-imidazol)-κ2N:N′)-bis(4-bromobenzoate-κ1O)cobalt(II)], C32H22Br2CoN4O4
  24. Crystal structure of (E)-5-propyl-4-((pyridin-2-ylmethylene)amino)-2,4-dihydro-3H-1,2,4-triazole-3-thione – methanol (1/1), C11H13N5S
  25. The crystal structure of (Z)-4-bromo-6-(((1,3-dihydroxy-2-(hydroxymethyl)propan-2-yl)amino)methylene)cyclohexa-2,4-dien-1-one monohydrate, C11H16BrNO5
  26. Crystal structure of bis(tetrapropylammonium) nonaselenidotetrastannate(IV), (Pr4N)2[Sn4Se9]
  27. Crystal structure of 2,6-di-tert-butyl-4-(4-chlorobenzylidene)cyclohexa-2,5-dien-1-one, C21H25ClO
  28. Crystal structure of (2,2′-((naphthalen-1-ylmethyl)azanediyl)diacetato-κ3 N,O,O′)-(1,10-phenanthroline-κ2 N,N′)-copper(II) trihydrate, CuC27H27N3O7
  29. The crystal structure of tetrakis(6-phenylpyridine-2-carboxylato-κ2N,O)-bis(1H-pyrazol-3-ylamine-κ2 N:N)dicobalt(II) dihydrate, C27H23N5O5Co
  30. The crystal structure of bis((E)-2-((tert-butylimino)methyl)-4-chlorophenolato-κ2N,O)zinc(II), C22H26Cl2N2O2Zn
  31. The crystal structure of poly[diaqua-(μ3-5-nitrobenzene-1,2,3-tricarboxylato-κ3O:O′:O′)-(μ2-4,4′-dipyridylamine-κ2N:N′)copper(II)], C38H30Cu3N8O20
  32. The crystal structure of (E)-1-ferrocenyl-3-(naphthalen-1-yl)prop-2-en-1-one, C23H18FeO
  33. The crystal structure of (E)-1-ferrocenyl-3-(4-isopropylphenyl)prop-2-en-1-one, C22H22FeO
  34. Crystal structure of 6-hydroxy-2,2-dimethyl-4Hbenzo[d][1,3]dioxin-4-one, C10H10O4
  35. The crystal structure of (2E,4E)-1-ferrocenyl-5-phenylpenta-2,4-dien-1-one, C21H18FeO
  36. Crystal structure of alaninato-κ2N,O-bis(hydroxylamido-κ2N,O)-oxido-vanadium(V), C3H10N3O5V
  37. Crystal structure of catena-poly[aqua-bis[μ2-6-(1H-imidazol-1-yl)nicotinato-κ2 N,O]copper(II)], C18H14N6O5Cu
  38. Crystal structure of diethyl 4,6-diphenyl-1,9-di-p-tolylhexahydro-3H-2,7,3,5-(epimethanetriyliminomethanetriyl)cyclopenta[b]pyridine-3,5(2H)-dicarboxylate, C42H42N2O4
  39. The crystal structure of cobalt cadmium bis(hydrogenphosphate) bis(phosphate(V)) tetrahydrate, H10O20P4Co3.14Cd1.86
  40. Crystal structure of dimethyl 1,4,6,9-tetraphenylhexahydro-3H-2,7,3,5-(epimethanetriyliminomethanetriyl)cyclopenta[b]pyridine-3,7(2H)-dicarboxylate, C38H34N2O4
  41. Crystal structure of (Z)-4-(furan-2-yl((4-iodophenyl)amino)methylene)-5-methyl-2(p-tolyl)-2,4-dihydro-3H-pyrazol-3-one, C21H16I N3O2
  42. Crystal structure of (E)-1-(4-(3,5-dimethoxystyryl)phenyl)-7-ethylheptanedioate, C25H30O6
  43. Crystal structure of 6-bromo-2-(4-chlorophenyl)chroman-4-one (6-bromo-4′-chloroflavanone), C15H10BrClO2
  44. The crystal structure of 2-(benzhydryloxy)-3-nitropyridine, C18H14N2O3
  45. The crystal structure of 1,3(4,1)-dipyridin-1-iuma-2(1,8)-diethynylanthracena-5(1,3)-benzenacyclohexaphane-11,31-diium bis(hexafluoridophosphate), C36H24F12N2P2
  46. Crystal structure of 3,6-di-tert-butyl-1-iodo-9-methyl-8-(pyren-1-ylethynyl)-9H-carbazole, C39H34IN
  47. The cocrystal 2-(dimethylammonio)-5-nitrobenzoate – 2-(dimethylamino)-5-nitrobenzoic acid, C9H10N2O4
  48. Crystal structure of 5-nitroquinazolin-4(3H)-one, C8H5N3O3
https://doi.org/10.1515/ncrs-2022-0018
Creative Commons
BY 4.0

Articles in the same Issue

  1. Frontmatter
  2. New Crystal Structures
  3. Crystal structure of (E)-(4-imidazol-1-yl-phenyl)-(2-methoxy-benzylidene)-amine monohydrate, C17H17N3O2
  4. Crystal structure of 6-methyl-3-(pyrrolidine-1-carbonyl)-2H-chromen-2-one, C15H15N1O3
  5. Crystal structure of 4-methyl-4-nitropentanoic acid, C6H11NO4
  6. The crystal structure of (E)-3-(furan-2-yl)acrylonitrile, C7H5NO
  7. Crystal structure of 3-(difluoromethyl)-1-methyl-N-(4,11,11-trimethyl-1,2,3,4-tetrahydro-1,4-methanoacridin-9-yl)-1H-pyrazole-4-carboxamide monohydrate, C23H26F2N4O3
  8. Crystal structure of 2-(4-bromobenzyloxy)-6-chloropyridine, C12H9BrClNO
  9. Crystal structure of N-(4-bromo-2,6-dichloro-phenyl)pyrazin-2-amine, C10H6BrCl2N3
  10. Crystal structure of (E)-1-(2–nitrophenyl)-3-phenylprop-2-en-1-one, C15H11NO3
  11. The crystal structure of (E)-3-chloro-2-(2-(4-fluorobenzylidene)hydrazinyl)pyridine, C12H9ClFN3
  12. Crystal structure of (E)-amino(2-(thiazol-2-ylmethylene)hydrazineyl)methaniminium nitrate, C10H16N12O6S2
  13. Crystal structure of 9-methoxy-2,3,4,4a,5,6-hexahydro-1H-pyrido [1′,2′:1,6]pyrazino[2,3-b]quinoxaline, C15H18N4O
  14. The crystal structure bis(dimethylsulfoxide-κ1O)-dipyridine-κ1 N-bis(m2-(Z)-3-methyl-2-oxido-N-((Z)-oxido(phenyl)methylene)benzohydrazonato-κ5)trinickel(II) - dimethylsulfoxide (1/2), C48H56N6Ni3O10S4
  15. Crystal structure of bis(bis(triphenylphosphine)iminium) tetradecacarbonyltetratelluridopentaferrate(2-), (PPN)2[Fe5Te4(CO)14]
  16. Crystal structure of 4-Hydroxy-3-(naphthalen-2-ylthio)pent-3-en-2-one, C15H14O2S
  17. The crystal structure of [(1,10-phenanthroline-κ2 N,N)-bis(6-phenylpyridine-2-carboxylate-κ2 N,O)nickel(II)] monohydrate, C36H26N4O5Ni
  18. Crystal structure of 3,3′-(pyridine-2,6-diylbis(methylene))bis(1-propyl-1H-imidazol-3-ium) ditetrafluoroborate, C19H27B2F8N5
  19. The crystal structure of (E)-1-(4-aminophenyl)-3-(p-tolyl)prop-2-en-1-one, C16H15NO
  20. The crystal structure of poly[(μ2-terephthalato-κ4O,O′: O″,O‴)-(μ4-terephthalato-κ4O:O′:O″:O‴)-{μ4-(1,2,4,5-tetrakis(1,2,4-triazol-1-ylmethyl)-benzene-κ4O:O′:O″,O‴)}dicadmium(II)] – water – acetronitrile (1/2/2), C38H36N14O10Cd2
  21. The crystal structure of diaqua-bis(6-phenylpyridine-2-carboxylato-κ2 N,O)cobalt(II)–water–N,N-dimethylformamide(1/2/1), C27H31N3O9Co
  22. The co-crystal structure of 4-hydroxy-3-methoxybenzoic acid – 4,4′-bipyridine, C8H8O4·C10H8N2
  23. Crystal structure of catena-poly[(μ2-1,1′-(biphenyl-4,4′-diyl)bis(1H-imidazol)-κ2N:N′)-bis(4-bromobenzoate-κ1O)cobalt(II)], C32H22Br2CoN4O4
  24. Crystal structure of (E)-5-propyl-4-((pyridin-2-ylmethylene)amino)-2,4-dihydro-3H-1,2,4-triazole-3-thione – methanol (1/1), C11H13N5S
  25. The crystal structure of (Z)-4-bromo-6-(((1,3-dihydroxy-2-(hydroxymethyl)propan-2-yl)amino)methylene)cyclohexa-2,4-dien-1-one monohydrate, C11H16BrNO5
  26. Crystal structure of bis(tetrapropylammonium) nonaselenidotetrastannate(IV), (Pr4N)2[Sn4Se9]
  27. Crystal structure of 2,6-di-tert-butyl-4-(4-chlorobenzylidene)cyclohexa-2,5-dien-1-one, C21H25ClO
  28. Crystal structure of (2,2′-((naphthalen-1-ylmethyl)azanediyl)diacetato-κ3 N,O,O′)-(1,10-phenanthroline-κ2 N,N′)-copper(II) trihydrate, CuC27H27N3O7
  29. The crystal structure of tetrakis(6-phenylpyridine-2-carboxylato-κ2N,O)-bis(1H-pyrazol-3-ylamine-κ2 N:N)dicobalt(II) dihydrate, C27H23N5O5Co
  30. The crystal structure of bis((E)-2-((tert-butylimino)methyl)-4-chlorophenolato-κ2N,O)zinc(II), C22H26Cl2N2O2Zn
  31. The crystal structure of poly[diaqua-(μ3-5-nitrobenzene-1,2,3-tricarboxylato-κ3O:O′:O′)-(μ2-4,4′-dipyridylamine-κ2N:N′)copper(II)], C38H30Cu3N8O20
  32. The crystal structure of (E)-1-ferrocenyl-3-(naphthalen-1-yl)prop-2-en-1-one, C23H18FeO
  33. The crystal structure of (E)-1-ferrocenyl-3-(4-isopropylphenyl)prop-2-en-1-one, C22H22FeO
  34. Crystal structure of 6-hydroxy-2,2-dimethyl-4Hbenzo[d][1,3]dioxin-4-one, C10H10O4
  35. The crystal structure of (2E,4E)-1-ferrocenyl-5-phenylpenta-2,4-dien-1-one, C21H18FeO
  36. Crystal structure of alaninato-κ2N,O-bis(hydroxylamido-κ2N,O)-oxido-vanadium(V), C3H10N3O5V
  37. Crystal structure of catena-poly[aqua-bis[μ2-6-(1H-imidazol-1-yl)nicotinato-κ2 N,O]copper(II)], C18H14N6O5Cu
  38. Crystal structure of diethyl 4,6-diphenyl-1,9-di-p-tolylhexahydro-3H-2,7,3,5-(epimethanetriyliminomethanetriyl)cyclopenta[b]pyridine-3,5(2H)-dicarboxylate, C42H42N2O4
  39. The crystal structure of cobalt cadmium bis(hydrogenphosphate) bis(phosphate(V)) tetrahydrate, H10O20P4Co3.14Cd1.86
  40. Crystal structure of dimethyl 1,4,6,9-tetraphenylhexahydro-3H-2,7,3,5-(epimethanetriyliminomethanetriyl)cyclopenta[b]pyridine-3,7(2H)-dicarboxylate, C38H34N2O4
  41. Crystal structure of (Z)-4-(furan-2-yl((4-iodophenyl)amino)methylene)-5-methyl-2(p-tolyl)-2,4-dihydro-3H-pyrazol-3-one, C21H16I N3O2
  42. Crystal structure of (E)-1-(4-(3,5-dimethoxystyryl)phenyl)-7-ethylheptanedioate, C25H30O6
  43. Crystal structure of 6-bromo-2-(4-chlorophenyl)chroman-4-one (6-bromo-4′-chloroflavanone), C15H10BrClO2
  44. The crystal structure of 2-(benzhydryloxy)-3-nitropyridine, C18H14N2O3
  45. The crystal structure of 1,3(4,1)-dipyridin-1-iuma-2(1,8)-diethynylanthracena-5(1,3)-benzenacyclohexaphane-11,31-diium bis(hexafluoridophosphate), C36H24F12N2P2
  46. Crystal structure of 3,6-di-tert-butyl-1-iodo-9-methyl-8-(pyren-1-ylethynyl)-9H-carbazole, C39H34IN
  47. The cocrystal 2-(dimethylammonio)-5-nitrobenzoate – 2-(dimethylamino)-5-nitrobenzoic acid, C9H10N2O4
  48. Crystal structure of 5-nitroquinazolin-4(3H)-one, C8H5N3O3
Sign up now to receive a 20% welcome discount
Institutional Access
How does access work?
Have an idea on how to improve our website?
Please write us.
© 2025 De Gruyter Brill
Downloaded on 19.12.2025 from https://www.degruyterbrill.com/document/doi/10.1515/ncrs-2022-0018/html?lang=en&srsltid=AfmBOooL4irTl7UCgqX9F3lV97qL60VbTRvjlldGqxNbobw3-S-vGX15
Scroll to top button